These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23412795)

  • 1. Comparative genomic hybridization of Wilms' tumor.
    Rassekh SR; Rajcan-Separovic E
    Methods Mol Biol; 2013; 973():249-65. PubMed ID: 23412795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for submicroscopic chromosomal rearrangements in Wilms tumor using whole-genome microarrays.
    Rassekh SR; Chan S; Harvard C; Dix D; Qiao Y; Rajcan-Separovic E
    Cancer Genet Cytogenet; 2008 Apr; 182(2):84-94. PubMed ID: 18406869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
    Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
    Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
    Kaneko Y; Homma C; Maseki N; Sakurai M; Hata J
    Cancer Res; 1991 Nov; 51(21):5937-42. PubMed ID: 1657374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms' tumor with an apparently balanced translocation t(X;18) resulting in deletion of the WTX gene.
    Han M; Rivera MN; Batten JM; Haber DA; Dal Cin P; Iafrate AJ
    Genes Chromosomes Cancer; 2007 Oct; 46(10):909-13. PubMed ID: 17620295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors.
    Hing S; Lu YJ; Summersgill B; King-Underwood L; Nicholson J; Grundy P; Grundy R; Gessler M; Shipley J; Pritchard-Jones K
    Am J Pathol; 2001 Feb; 158(2):393-8. PubMed ID: 11159177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
    Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome analysis of 31 Wilms' tumors.
    Sheng WW; Soukup S; Bove K; Gotwals B; Lampkin B
    Cancer Res; 1990 May; 50(9):2786-93. PubMed ID: 2158398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization.
    Altura RA; Valentine M; Li H; Boyett JM; Shearer P; Grundy P; Shapiro DN; Look AT
    Cancer Res; 1996 Aug; 56(16):3837-41. PubMed ID: 8706032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Der(16)t(1;16)(q21;q13) in Wilms' tumor: friend or foe.
    Mathew P; Douglass EC; Jones D; Valentine M; Valentine V; Rowe S; Shapiro DN
    Med Pediatr Oncol; 1996 Jul; 27(1):3-7. PubMed ID: 8614388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of limited regions of genetic aberrations in patients affected with Wilms' tumor using a tiling-path chromosome 22 array.
    Benetkiewicz M; Díaz de Ståhl T; Gördör A; Pfeifer S; Wittmann S; Gessler M; Dumanski JP
    Int J Cancer; 2006 Aug; 119(3):571-8. PubMed ID: 16496407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
    Pritchard-Jones K; Fleming S
    Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.
    Chiang MR; Kuo CW; Wang WC; Hou TC; Kuo CY; Lu MY; Lai YC
    Pathol Oncol Res; 2019 Jul; 25(3):1199-1206. PubMed ID: 30671724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cytogenetic study of Wilms' tumor.
    Slater RM; de Kraker J; Voûte PA; Delemarre JF
    Cancer Genet Cytogenet; 1985 Jan; 14(1-2):95-109. PubMed ID: 2981155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of array comparative genomic hybridization in cytogenetic analysis.
    Singh RR; Cheung KJ; Horsman DE
    Methods Mol Biol; 2011; 730():219-34. PubMed ID: 21431645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilms' tumour as a paradigm for the relationship of cancer to development.
    Pritchard-Jones K; Hastie ND
    Cancer Surv; 1990; 9(3):555-78. PubMed ID: 1966278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic hybridization and its application to Wilms' tumorigenesis.
    Getman ME; Houseal TW; Miller GA; Grundy PE; Cowell JK; Landes GM
    Cytogenet Cell Genet; 1998; 82(3-4):284-90. PubMed ID: 9858837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
    Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
    Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNP-based arrays complement classic cytogenetics in the detection of chromosomal aberrations in Wilms' tumor.
    Zin R; Pham K; Ashleigh M; Ravine D; Waring P; Charles A
    Cancer Genet; 2012 Mar; 205(3):80-93. PubMed ID: 22469507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the PAX2 gene in human fetal kidney and Wilms' tumor.
    Eccles MR; Wallis LJ; Fidler AE; Spurr NK; Goodfellow PJ; Reeve AE
    Cell Growth Differ; 1992 May; 3(5):279-89. PubMed ID: 1378753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.